Grants and Contributions

About this information

In June 2016, as part of the Open Government Action Plan, the Treasury Board of Canada Secretariat (TBS) committed to increasing the transparency and usefulness of grants and contribution data and subsequently launched the Guidelines on the Reporting of Grants and Contributions Awards, effective April 1, 2018.

The rules and principles governing government grants and contributions are outlined in the Treasury Board Policy on Transfer Payments. Transfer payments are transfers of money, goods, services or assets made from an appropriation to individuals, organizations or other levels of government, without the federal government directly receiving goods or services in return, but which may require the recipient to provide a report or other information subsequent to receiving payment. These expenditures are reported in the Public Accounts of Canada. The major types of transfer payments are grants, contributions and \'other transfer payments\'.

Included in this category, but not to be reported under proactive disclosure of awards, are (1) transfers to other levels of government such as Equalization payments as well as Canada Health and Social Transfer payments. (2) Grants and contributions reallocated or otherwise redistributed by the recipient to third parties; and (3) information that would normally be withheld under the Access to Information Act and the Privacy Act.

Grants and Contributions Dataset
Found 1159 records

-

Agreement:

220969

Number:

220969

Duration: from Sep 20, 2022 to Mar 31, 2023
Description:

Install solar power in the therapy center and build a second-floor treatment area

Organization: Atlantic Canada Opportunities Agency
Program Name: ICF - Building or improving community infrastructure (CCRF)
Location: Saint John, NB, CA E2P 1K4

$75,000.00

Sep 15, 2022

For-profit organization

Agreement:

Development of a novel mRNA therapy encoding a hepatokine

Number:

995579

Duration: from Sep 15, 2022 to Mar 31, 2023
Description:

This project will involve the development of a proprietary lipid nanoparticle (LNP)-mRNA technology for the safe and effective delivery of mRNA encoding the hepatokine Fibroblast Growth Factor 21 (FGF21) as a hepatic gene therapy to promote weight loss in a diet-induced obesity models.

Organization: National Research Council Canada
Program Name: Industrial Research Assistance Program – Contributions to Firms
Location: Vancouver, BC, CA V6T 1Z3

Academia

Agreement:

Early detection of cognitive decline using epigenetic biomarkers in peripheral blood

Number:

991333

Duration: from Sep 1, 2022 to Aug 31, 2025
Description:

Such a predictor would enable us to identify those people at greatest risk of developing the disease earlier, when disease modifying therapies are deemed most effective, reducing the need for long-term care and increasing quality of life.

Organization: National Research Council Canada
Program Name: Collaborative Science, Technology and Innovation Program - Collaborative R&D Initiatives
Location: Montreal, QC, CA H3T 1E2

$30,000.00

Sep 1, 2022

Individual or sole proprietorship

Agreement:

Graduate Student Awards in Asthma - Doctoral

Number:

167086

Duration: from Sep 1, 2022 to Aug 31, 2023
Description:

To create value-added opportunities for the training, education, and professional development of graduate students, to ensure continued improvement of asthma treatment therapies and progress towards finding a cure for asthma.

Organization: Canadian Institutes of Health Research
Program Name: Research in Priority Areas
Location: Vancouver, BC, CA V6T 1Z1

$8,334.00

Sep 1, 2022

Individual or sole proprietorship

Agreement:

Graduate Student Awards in Asthma - Master’s

Number:

167088

Duration: from Sep 1, 2022 to Aug 31, 2023
Description:

To create value-added opportunities for the training, education, and professional development of graduate students, to ensure continued improvement of asthma treatment therapies and progress towards finding a cure for asthma.

Organization: Canadian Institutes of Health Research
Program Name: Research in Priority Areas
Location: Vancouver, BC, CA V6T 1Z1

$84,028.00

Sep 1, 2022

Academia

Agreement:

User-requirements for an in-home, augmented reality, physical rehabilitation tool for an aging population

Number:

995744

Duration: from Sep 1, 2022 to Mar 31, 2025
Description:

Older adults experience barriers to achieving full postoperative potential during conventional, unsupervised in-home therapy, underscoring the need for innovative rehabilitation tools after total joint replacement (TJR).

Organization: National Research Council Canada
Program Name: Collaborative Science, Technology and Innovation Program - Collaborative R&D Initiatives
Location: Kingston, ON, CA K7L 3N6

Government

Agreement:

Digital therapeutics for older adults: using mobile technology to deliver therapies anytime and anywhere

Number:

996558

Duration: from Sep 1, 2022 to Aug 31, 2025
Description:

Non-pharmacological interventions centered around lifestyle modifications constitute promising approaches to delay the onset or progression of neurodegenerative diseases impacting cognition. An important challenge for the implementation of such interventions is the ability to deliver them in an accessible PAGE 4 and ecological context. To address these challenges, mobile technologies have been increasingly used over the past decade to provide health-related assessments or interventions for older adults in their own living environment. The extent to which mobile assessments and interventions can be integrated to improve health outcomes deserves further investigation. In this project, we will investigate the feasibility and benefits of developing and using a digital phenotyping approach based on remote assessments of sleep and cognition in older adults in the community. We will then explore whether such digital phenotyping may improve the outcomes of a web-based intervention that was developed to promote better sleep and brain health in older adults. This phenotyping approach will allow to collect information on lifestyle factors such as sleep, passively using sensors and actively via short surveys and tasks. Using it, the CRIUGM will run several user-based studies and validate its feasibility with older adults. The integration of measures from the phenotyping approach into the web-based intervention platform is to be used to improve an online sleep-related intervention by tailoring it to the individual’s needs. In addition, it is expected that this integration between remote assessments and intervention will also improve personalized feedback to the user during the intervention, and therefore improve acceptability, engagement, and adherence of older adults to the intervention.

Organization: National Research Council Canada
Program Name: Collaborative Science, Technology and Innovation Program - Collaborative R&D Initiatives
Location: Montreal, QC, CA H3W 1W5

$72,000.00

Sep 1, 2022

For-profit organization

Agreement:

Business Innovation - New sales motion and deployment/fulfilment process to increase referral ratio and 10x Monthly Revenue

Number:

995725

Duration: from Sep 1, 2022 to Mar 31, 2023
Description:

This project will allow the firm, with the recently-hired clinical relations manager, marketing associate and marketing COOP, to develop and experiment with new B2B2C commercial deployment and fulfilment processes to increase market penetration of the Tenzr system for Physical Therapy.

Organization: National Research Council Canada
Program Name: Industrial Research Assistance Program – Contributions to Firms
Location: Coquitlam, BC, CA V3E 3H1

For-profit organization

Agreement:

Selection and characterization of humanized antibody candidate for the treatment of kappa light chain amyloidosis

Number:

994401

Duration: from Aug 8, 2022 to Feb 28, 2023
Description:

There are currently no existing therapies that direct remove these deposits from organs.

Organization: National Research Council Canada
Program Name: Industrial Research Assistance Program – Youth Employment Program
Location: Toronto, ON, CA M5G 0B7

$217,397.00

Aug 1, 2022

Academia

Agreement:

Clinical CAR-T cell raman spectroscopy analysis

Number:

996027

Duration: from Aug 1, 2022 to Jul 31, 2024
Description:

The approval of chimeric antigen receptor T-cell (CAR-T) therapies has been a major breakthrough for patients with relapsed or refractory blood cancers. However, CAR-T cells are highly complex, live cell therapies, and it has proven difficult to predict CAR-T cell potency.

Organization: National Research Council Canada
Program Name: Collaborative Science, Technology and Innovation Program - Collaborative R&D Initiatives
Location: Vancouver, BC, CA V6T 1Z4
Date modified: